Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence (PROTOGLUT)

September 18, 2025 updated by: University Hospital, Rouen

Urinary incontinence (UI) is estimated to affect 25% à 45 % women all over the world. UI is associated with a poor Quality of life, with a strong level of certainty. Stress urinary incontinence (SUI) is the second more prevalent type of UI . First-line treatment for SUI is conservative, non-drug and non-surgical treatment. Among these techniques, physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) as a first-line treatment; however, only half of women with SUI are cured with PFMT.

Brain imaging shows that PFMs (involved in continence mechanisms) and gluteal muscles can activate the same cortical region. This synergy is found if the gluteal muscles are voluntarily activated, but not if the PFMs are volontary activated alone . In women, hip abductor physiotherapy is a common practice which has already been the subject of a very extensive literature and has largely shown its effectiveness in the quality of lumbo-pelvic control, balance, quality of life and risk of fall prevention. This rehabilitation is based on exercises that induce solicitation of the hip abductors by synergistic reflex activation during a range of well-known exercises. Recent work has shown the effect of hip abductors on the activation of the PFMs . Until today, there is no literature evaluating the effectiveness of a hip abductors training program without associated voluntary contraction of the PFMs (PPM) on UI. The hypothesis of this work will be to demonstrate that a complementary training focused on the hip abductor, complementary to concomitant PFMT, would benefit from a more significant improvement in continence, and also in physical abilities and quality of life. Because balance seems involved in UI, we therefore propose to to observe the effects on the frontal balance of the pelvis. As the investigators have already done in previous studies, to identifying factors that predict the success of our interventions, investiagtors have planned to evaluate the observance and adherence of our patients .Complementary, the investigators planned to evaluate the effect of both intervention on pelvic floor muscles and hip abductors strength and endurance, pelvic organ prolapse symptoms and quality of life. For this objective, the investigators intend to compare two randomized parallel groups: Group A follow a 12 sessions supervised PFMT + home based PFMs exercices. Group B follow a 12 sessions supervised PFMT + home based hip abductor exercices.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Caen, France
        • Recruiting
        • Pôle santé de la Grace Dieu
        • Contact:
      • Rouen, France
      • Saint-Étienne-du-Rouvray, France
        • Recruiting
        • Médipôle du Rouvray
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women ≥ 18 ans
  • patient with urinary incontinence according to the ICS criteria [3]
  • having received a prescription for perineal rehabilitation
  • affiliated to french health care insurance
  • Patient having read and understood the information letter and signed the consent form
  • Effective contraception in women of childbearing age (negative urine pregnancy test). For postmenopausal women, a confirmatory diagnosis must be obtained (amenorrhea for at least 12 months before the inclusion visit)

Exclusion Criteria:

  • Bladder pathologies (cyst, tumour, interstitial cystitis)
  • Neurological pathologies (multiple sclerosis, Parkinson's desease, etc.)
  • Pregnant or parturient or breastfeeding woman or absence of proven contraception
  • Person deprived of liberty by administrative or judicial decision or a person placed under the safeguard of justice, or guardianship or curatorship
  • Physical inability to perform hip abductors exercises (unable to walk or stand independently)
  • Women having scheduled continence surgery before the end of physiotherapy sessions at the time of randomization
  • Women having at least one of the continence-specific anticholinergic treatments prescribed before the end of the physiotherapy sessions at the time of randomization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: physiotherapist-supervised pelvic floor muscle training
physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) and self training PFMT
Standard pelvic floor muscle training
Standard pelvic floor muscle training self training
Experimental: hip abductors self training program
physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) and self training hip abductors self training program
Standard pelvic floor muscle training
hip abductors self training program during 7 to 10 weeks associate with a PFMT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The difference in the number of leaks per week observed after the end of treatment between the two arms at the last physiotherapy session.
Time Frame: 10 weeks
This number of leaks per week will be recorded using question 3 of the International Consultation on Incontinence Questionnaire (ICIQ-SF).
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement in centimeters of the offset in the frontal plane of the postero-superior iliac spines during a one leg stance
Time Frame: 10 weeks
10 weeks
Average of the measurement in Newton of the force of the hip abductors during a maximum manual resistance test repeated 3 times using a dynamometer
Time Frame: 10 weeks
10 weeks
Average of measurement in seconds of the hip abductors resistance during a manual resistance test repeated 10 times
Time Frame: 10 weeks
10 weeks
Measurement rated from 1 to 5 of the strength of PFMs according to the "Modified Oxford Grading Scale" testing
Time Frame: 10 weeks
10 weeks
Overall score and sub-scores of urinary symptoms from the international consultation on incontinence questionnaire
Time Frame: 10 weeks
min: 0 : better outcome max : 21 worse outcome
10 weeks
Overall score and sub-scores of urinary symptoms of the Prolape quality of life questionnaire
Time Frame: 10 weeks
10 weeks
Short Form-36 Quality of Life overall score and subscores
Time Frame: 10 weeks
10 weeks
Overall score and sub-scores of physical inactivity and physical abilities from the Ricci & Gagnon questionnaire
Time Frame: 10 weeks
10 weeks
Overall score and sub-scores of the therapeutic observance and adherence questionnaire (only at the end of treatment)
Time Frame: 10 weeks
10 weeks
Patient Global Impression of Improvement (PGI-I) questionnaire score (only at end of treatment)
Time Frame: 10 weeks
10 weeks
Overall score and sub-scores of urinary symptoms from the international consultation on incontinence questionnaire questionnaire
Time Frame: through study completion, an average of 6 month
through study completion, an average of 6 month
Overall score and sub-scores of urinary symptoms of the Prolapsus Quality of Life questionnaire 3. SF-36 Quality of Life overall score and subscores
Time Frame: throught study completion, an average of 6 month
throught study completion, an average of 6 month
Overall score and sub-scores of physical inactivity and physical abilities from the Ricci & Gagnon questionnaire
Time Frame: throught study completion, an average of 6 month
throught study completion, an average of 6 month
Score du questionnaire Patient Global Impression of Improvement (PGI-I)
Time Frame: throught study completion, an average of 6 month
min: 1 better outcome max : 7 worse outcome
throught study completion, an average of 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

September 23, 2026

Study Registration Dates

First Submitted

November 3, 2022

First Submitted That Met QC Criteria

November 22, 2022

First Posted (Actual)

December 2, 2022

Study Record Updates

Last Update Posted (Estimated)

September 24, 2025

Last Update Submitted That Met QC Criteria

September 18, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Women With Stress Urinary Incontinence

Clinical Trials on Standard pelvic floor muscle training

Subscribe